Kimberly R Saverno

4PUBLICATIONS
5CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 15, 2026
Real-world use of tafasitamab for relapsed or refractory diffuse large B-cell lymphoma among racial and ethnic minorities in the United States.

|Jan 24, 2025
Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma.

Narendranath Epperla, Loretta J Nastoupil, Bruce Feinberg

|Aug 22, 2024
Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US.

Kim Saverno, Kristin M Zimmerman Savill, Cherrishe Brown-Bickerstaff

|Sep 13, 2022
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib.

Emily Nash Smyth, Julie Beyrer, Kimberly R Saverno

Pageof 1

Frequent Collaborators

1 joint publications

Richard Kim

1 joint publications

Narendranath Epperla

1 joint publications

Emily Nash Smyth

1 joint publications

Julie Beyrer